Abstract: An object of the present invention is to provide a liposome composition and a pharmaceutical composition, which exhibit a high AUC. Provided are a liposome composition including a hydrophilic polymer-modified diacylphosphatidylethanolamine, a dihydrosphingomyelin, and cholesterols as components of a liposome membrane, in which the liposome composition encapsulates a drug, an inner water phase thereof contains ammonium sulfate, and a molar ratio of sulfate ions in the inner water phase to the drug in an entire water phase is 0.36 or more; and a pharmaceutical composition including the liposome composition.

Abstract: A user can easily grasp a state of wearing clothing, and information regarding coordination corresponding to the clothing is provided to the user. An information processing apparatus according to the present disclosure includes a communication interface that performs communication with an information providing apparatus that provides coordination information regarding coordination of clothing, and a controller that displays, using a display apparatus mounted on a vehicle, an image of a state in which a user is virtually wearing clothing. The controller transmits the image to the information providing apparatus and receives coordination information, provided by the information providing apparatus, corresponding to the image, via the communication interface, and informs the user of the coordination information received.

Abstract: An organic compound is represented by formula (1). In the formula (1), R1 to R24 are each independently selected from the group consisting of a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted amino group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aryloxy group, a silyl group, and a cyano group.

Abstract: A user can easily grasp a state of wearing clothing, and information regarding coordination corresponding to the clothing is provided to the user. An information processing apparatus according to the present disclosure includes a communication interface that performs communication with an information providing apparatus that provides coordination information regarding coordination of clothing, and a controller that displays, using a display apparatus mounted on a vehicle, an image of a state in which a user is virtually wearing clothing. The controller transmits the image to the information providing apparatus and receives coordination information, provided by the information providing apparatus, corresponding to the image, via the communication interface, and informs the user of the coordination information received.

Abstract: An organic compound represented by formula [1], where in formula [1], R1 to R8 are each independently selected from the group consisting of a hydrogen atom, a halogen atom, an alkyl group, and other substituents, and X1 is oxygen, sulfur, selenium, tellurium, or a CR9R10 group, in which R9 and R10 are each independently selected from the group consisting of a hydrogen atom, a halogen atom, an alkyl group, and other substituents, and at least one of R1 to R8 is a group represented by formula [2].

Abstract: An information processing apparatus includes a controller. The controller is configured to execute: acquiring a presence or an absence of a predetermined input from the outside to parked vehicles parked in a predetermined parking area in which a plurality of vehicles are parked, identifying a vehicle target vehicle for which the predetermined input is made among the parked vehicles, and issuing a command for activating a first vehicle sensor configured to detect a peripheral information of a first vehicle and provided to the first vehicle based on the predetermined input to target vehicle, the first vehicle being a vehicle parked around target vehicle in the predetermined parking area.

Abstract: An organic compound represented by formula (1). In formula (1), each of R1 to R22 is independently selected from the group consisting of a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted amino group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aryloxy group, a silyl group, and a cyano group.

Abstract: An object of the present invention is to provide a liposome composition and a pharmaceutical composition, which exhibit a high AUC. Provided are a liposome composition including a hydrophilic polymer-modified diacylphosphatidylethanolamine, a dihydrosphingomyelin, and cholesterols as components of a liposome membrane, in which the liposome composition encapsulates a drug, an inner water phase thereof contains ammonium sulfate, and a molar ratio of sulfate ions in the inner water phase to the drug in an entire water phase is 0.36 or more; and a pharmaceutical composition including the liposome composition.

Abstract: An organic compound is represented by formula (1). In the formula (1), R1 to R24 are each independently selected from the group consisting of a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted amino group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aryloxy group, a silyl group, and a cyano group.

Abstract: The present disclosure provides an organic compound that has a mother skeleton with a fused-ring structure, an electron-withdrawing group bonded to the mother skeleton, and an electron-donating group bonded to the mother skeleton, wherein the electron-withdrawing group is bonded at a position satisfying the following relationship in the mother skeleton.

Abstract: An organic compound represented by formula [1]: where R1 to R14 are each independently selected from the group consisting of a hydrogen atom and substituents, wherein at least one of R1 to R4 and R8 to R11 is an amino group or an amino group-containing group, and X is oxygen, sulfur, selenium, tellurium, or a CR15R16 group, wherein R15 and R16 are each independently selected from the group consisting of a hydrogen atom and substituents.

Abstract: An object of the present invention is to provide a liposome composition and a pharmaceutical composition, which exhibit a high AUC. Provided are a liposome composition including a hydrophilic polymer-modified diacylphosphatidylethanolamine, a dihydrosphingomyelin, and cholesterols as components of a liposome membrane, in which the liposome composition encapsulates a drug, an inner water phase thereof contains ammonium sulfate, and a molar ratio of sulfate ions in the inner water phase to the drug in an entire water phase is 0.36 or more; and a pharmaceutical composition including the liposome composition.

Abstract: An organic compound, represented by formula [1] or [2], suitably used for a thermally activated delayed fluorescent device: where X1 to X18 and X21 to X38 are each independently selected from the group consisting of a hydrogen atom, and substituents, Y is oxygen, sulfur, selenium, tellurium, a CR1R2 group, or a carbonyl group, where R1 and R2 are each independently selected from the group consisting of a hydrogen atom, and substituents, and Z is an alkyl group, an aryl group, or a heterocyclic group.

Abstract: An organic light emitting element includes, in sequence, an anode, a first light emitting layer, a second light emitting layer, and a cathode. The first light emitting layer includes a first compound and a first light emitting material. The second light emitting layer includes a second compound and a second light emitting material having an energy gap different from an energy gap of the first light emitting material. The organic light emitting element satisfies relations (a) to (c). LUMO(H1)>LUMO(D1)??(a) LUMO(H2)>LUMO(D2)??(b) LUMO(H2)?LUMO(D2)>LUMO(H1)?LUMO(D1)??(c) Where LUMO (H1), LUMO (D1), LUMO (H2), and LUMO (D2) represent a LUMO level of the first compound, a LUMO level of the first light emitting material, a LUMO level of the second compound, and a LUMO level of the second light emitting material, respectively.

Abstract: Provided is a system including a vehicle loaded with equipment to be used in a health checkup, a server configured to decide a dispatch schedule of the vehicle, and a terminal apparatus used by the user. The server sets the equipment to be loaded onto the vehicle based on information about the user transmitted from the terminal apparatus or information about the user stored in a database, and additionally decides the dispatch schedule for the vehicle. The terminal apparatus and the vehicle receives the dispatch schedule from the server, and the vehicle is driven based on the dispatch schedule.

Abstract: An organic light-emitting element including a first electrode, a second electrode, and a light-emitting layer located between the first electrode and the second electrode. The light-emitting layer contains a first organic compound material, a second organic compound that is a delayed fluorescent material, and a third organic compound that is a light-emitting material. In the second organic compound, an electron is transferred from a plurality of occupied molecular orbitals (OMO) to a lowest unoccupied molecular orbital (LUMO) in a second excited triplet state.

Abstract: Disclosed herein are a method for producing a liposome which is capable of reducing the facility costs and also capable of rapid desolvation, and an apparatus for producing a liposome which is for use in the above-mentioned method. Provided is a method for producing a liposome, including a stirring step of stirring a mixed liquid containing an oil phase in which at least one lipid is dissolved in an organic solvent and a water phase, and an evaporating step of evaporating an organic solvent from the mixed liquid, in which the condensed organic solvent is removed by passing a gas having a temperature not higher than the dew point of the solvent in the evaporating step.

Abstract: An organic compound is represented by general formula [1-1]. In general formula [1-1], X is an oxygen atom, a sulfur atom, a selenium atom, or a tellurium atom, and R1 to R18 are each independently selected from the group consisting of a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted amino group, a substituted or unsubstituted aromatic hydrocarbon group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted silyl group, and a cyano group.

Abstract: The present invention provides a thin-film forming raw material including a scandium compound represented by the following general formula (1), a method of producing a thin-film including using the thin-film forming raw material, and a novel scandium compound: where R1 represents an alkyl group having 1 to 4 carbon atoms, R2 represents an alkyl group having 2 or 3 carbon atoms, and R3 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.

Abstract: The present invention is directed to provide antitumor agent including water-soluble sulfasalazine as an active ingredient. Antitumor agents were obtained with, as the water-soluble sulfasalazine, a PEG-modified sulfasalazine represented by the following formula: wherein an average value of n is 4 or larger and 1136 or smaller.